Categories: News

SPR Therapeutics CEO Maria Bennett Selected as Winner of EY Entrepreneur of the Year in East Central Region

CLEVELAND, Aug. 06, 2021 (GLOBE NEWSWIRE) — SPR Therapeutics is proud to announce that President, Founder and CEO Maria Bennett has been selected as an Ernst & Young (EY) Entrepreneur Of The Year® 2021 East Central Award winner. Bennett was selected from a prestigious list of finalists in the region recognizing those who are unstoppable entrepreneurial leaders, excelling in talent management; degree of difficulty; financial performance; societal impact and building a values-based company; and originality, innovation and future plans

The independent judging panel includes previous award winners, leading CEOs, private equity and venture capital investors, and other regional business luminaries. As a regional award winner, Bennett is eligible for the Entrepreneur Of The Year National Awards, presented in November. The national overall award winner will go on to compete for the EY World Entrepreneur Of The Year™ Award in June 2022.

“I’m honored to receive this award on behalf of everyone at SPR that works with unparalleled commitment to improve the lives of millions suffering with pain,” said Maria Bennett. “Since founding SPR, we have collectively changed the lives of thousands of patients and are experiencing tremendous growth to continue to achieve our mission. As an entrepreneur and leader, that progress is extremely rewarding, I look forward to our continued success and development with my outstanding team and our physician partners. I thank EY for their support of this award and entrepreneurs everywhere.”

About EY Entrepreneur Of The Year®
Entrepreneur Of The Year® is the world’s most prestigious business awards program for unstoppable entrepreneurs. These visionary leaders deliver innovation, growth and prosperity that transform our world. The program engages entrepreneurs with insights and experiences that foster growth. It connects them with their peers to strengthen entrepreneurship around the world. Entrepreneur Of The Year is the first and only truly global awards program of its kind. It celebrates entrepreneurs through regional and national awards programs in more than 145 cities in over 60 countries. National overall winners go on to compete for the EY World Entrepreneur Of The Year™ title. ey.com/us/eoy

About SPR Therapeutics, Inc.
SPR Therapeutics is a privately-held medical device company, providing patients with a non-opioid, minimally invasive pain treatment option. Our SPRINT® PNS System fulfills a critical unmet need for a drug-free, surgery-free option for millions who suffer from chronic pain. Backed by the largest body of clinical evidence, SPR has demonstrated commercial demand in untapped peripheral (shoulder and knee) and back pain markets and built an incredibly strong foundation for commercial growth. Headquartered in Cleveland, OH with satellite offices in Chapel Hill, NC and Minneapolis, MN, SPR’s Senior Management team includes experienced industry veterans with nearly 200 years of collective pain market and MedTech expertise, all driven by our purpose – to improve the quality of patients’ lives by providing them with a minimally-invasive, drug-free, surgery-free solution to manage their acute and chronic pain.

More information can be found at www.SPRTherapeutics.com.

CONTACT: SPR Contacts:

Dave Folkens
Public Relations Contact
dfolkens@sprtherapeutics.com
612.978.6547

Mark Stultz
Senior Vice President Market Development
mstultz@sprtherapeutics.com        
612.770.0390        

Staff

Recent Posts

ZetrOZ System’s sam(R) Ultrasound Treatment Helps Top Triathlete Return to the Boston Marathon

Former triathlon champ Claudia McCoy used the breakthrough wearable ultrasound unit to boost her recovery…

3 minutes ago

Coro Medical Prepares to Roll Out Project AED365 Nationwide Donation Initiative

Project AED365 Aims to Empower Communities, Youth Organizations, First Responders, and more by Providing Lifesaving Automated…

3 hours ago

NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Filing of F-4 Registration Statement with the SEC Ahead of Proposed Merger

The proposed transaction will create a Nasdaq-traded, biotechnology company with product candidates in advanced stages…

3 hours ago

Blazesoft Spreads Holiday Cheer with $250,000 Donation to Mackenzie Health Foundation

This heartfelt donation demonstrates Blazesoft's commitment to corporate social responsibility with a generous gift to…

3 hours ago

Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device

GOLETA, Calif.--(BUSINESS WIRE)--$INGN #AirwayClearance--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products…

6 hours ago

Bemax Inc. Announces Second Quarter Financial Results

- Revenue grew to $1,078,090, an increase of over $1million year-over-yearDallas, Georgia--(Newsfile Corp. - December…

6 hours ago